Patient Worthy

Cholangiocarcinoma

TransThera Secures China’s First Approval for Patients With FGFR Inhibitor-Resistant Cholangiocarcinoma

Austin Newman - August 20, 2026

Chronic obstructive pulmonary disease (COPD)

Zydus Introduces India’s First Once-Daily Nebulized LAMA for COPD Maintenance

Chronic Kidney Disease

New Treatment Expands Kidney Transplant Options in Australia

non-small cell lung cancer

AstraZeneca Ends Phase 3 Volrustomig Study in Lung Cancer After Interim Review Signals Low Likelihood of Success

LISTEN TO OUR PODCAST

THE LATEST FROM PATIENT WORTHY

Psoriatic Arthritis

Tirzepatide May Enhance Biologic Therapy Outcomes in Psoriatic Arthritis Patients With Obesity

New observational research suggests that addressing obesity alongside inflammatory joint disease could improve treatment outcomes for people with psoriatic arthritis (PsA). As reported on MedIndia,

Primary Biliary Cholangitis

Impending PPAR-Targeted Therapies Expand Treatment Possibilities for Primary Biliary Cholangitis

As reported on News Medical, researchers are highlighting a new class of therapies that could improve outcomes for people living with primary biliary cholangitis (PBC),

Lung Cancer

Caspase-1 Inhibition Shows Promise as a New Strategy to Prevent Lung Cancer

Researchers at MIT have identified a potential new approach to reducing lung cancer risk by targeting caspase-1, an enzyme involved in inflammation. Findings published in

Rare Disease

LEVI-04 Shows Promise as a Novel Non-Opioid Therapy for Knee Osteoarthritis in Phase 2 Trial

A recent study shared by The Lancet shows that a first-in-class investigational therapy targeting neurotrophin-3 (NT-3) significantly reduced pain and improved function in patients with

Cancer

Keytruda is Called a Blockbuster Drug and Deserves Its Reputation

As reported by the ICIJ, the FDA originally approved Keytruda (pembrolizumab) combined with cisplatin and gemcitabine on October 31, 2023, to treat locally advanced inoperable

Rare Disease

How Creative Activities Help You Manage Stress and Feel Better

Editor’s Note: Patient Worthy is honored to present this article, originally written by Camille Johnson. People living with chronic illness or long-term treatment plans often

Rare Disease

End Sepsis – Rory’s Story

Editor’s Note: Patient Worthy is honored to share this article with you, kindly provided to us by our friends at End Sepsis. To see the

non-small cell lung cancer

Back on the Ice: My Journey with Advanced Lung Cancer

If you had asked me a few years ago what I thought my biggest health concern would be, lung cancer wouldn’t have even crossed my

Hereditary ATTR Amyloidosis

Is it a Zebra? A Horse? And Does That Even Matter?

Reflections on V122I, Genetic Risk, and the Questions Black Families Are Still Asking Editor’s Note: This article was written and submitted to us by Erin

Rare Disease

Treating Inflammation vs. Bacteria

According to recent reports, assistant pediatric professor at the Boston Children’s Hospital, Prof. Meenakshi Rao, noted that infections associated with Clostridioides difficile (C. Diff.) are difficult to eradicate. Nonetheless,

Alpha-1 antitrypsin deficiency

My Insurance Covered My Treatment. I Still Couldn’t Get It.

For more than 20 years, I had a treatment routine that worked. My specialty pharmacy delivered the medications I needed and coordinated trained nurses who

Ebola

Ebola – Lessons Learned

The Ebola outbreak in DR Congo was declared in May 2026. It is now the second worst on record with estimates that the death toll

Parkinson's Disease

ABLi Therapeutics Parkinson’s Research Results

As shared on GlobeNewswire, a biotechnology company called ABLi Therapeutics has released encouraging findings from a research study on a potential new Parkinson’s treatment called

Rare Disease

Samsung Secures FDA Clearance for Galaxy Buds Hearing Assistance Technology

As reported on Fierce Biotech, Samsung Electronics has obtained clearance from the U.S. Food and Drug Administration (FDA) for software features that transform select Galaxy

Cockayne syndrome

First Patient in the World Treated With Gene Therapy for Cockayne Syndrome

Editor’s Note: This article was shared with us by Jo Kaur. To see it in its original format, please click here. Riaan Singh Digeorge,

Rare Disease

Qiagen Secures FDA Clearance for First QIAstat-Dx Bloodstream Infection Test in the US

As reported on PharmaBiz, Qiagen has received US Food and Drug Administration (FDA) clearance for its QIAstat-Dx BCID GPF Plus AMR Panel, marking the company’s

Spinal Muscular Atrophy

England to Add Spinal Muscular Atrophy to Newborn Screening Program in 2027

As reported on MedIndia, England is set to introduce nationwide newborn screening for spinal muscular atrophy (SMA) in October 2027, a move designed to accelerate

IgA Nephropathy

Otsuka Reports Two-Year Kidney Function Benefit With Sibeprenlimab in Phase 3 IgA Nephropathy Trial

Sibeprenlimab-szsi (VOYXACT) slowed estimated glomerular filtration rate decline versus placebo over 24 months in adult patients with primary IgA nephropathy, according to Phase 3 VISIONARY